UK VBP - paddling back big time ?

Dear All,

it took some time for the UK government to come out with something on the VBP debate. Now the first details of the new "deal" emerged. What is now on the table looks quite different from what was set out as an objective, but not at all from what has been done so far. Of course we are not surprised knowing all along how difficult it is to implement something that sounds easy in theory. Pretty much everything stays the same, the threshold, NICE doesn't have a role in price setting apart from some wider  benefits to the society are now supposed to be included in the assessment of new drugs.

Below a bit of reading on the topic.

Cheers
Ulf

http://blogs.nature.com/news/2013/11/uk-backs-away-from-value-based-pricing-for-drugs.html
http://www.pharmexec.com/pharmexec/Noteworthy/What-Does-the-UKs-New-PPRS-Mean-for-Value-Based-Pr/ArticleStandard/Article/detail/828958?contextCategoryId=48158